Eva Fellinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Eva Fellinger has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Annette Schmidt
Institute of Sports Science, University of the Bundeswehr Munich, 85579 Neubiberg, Germany
3 shared publications - Tom Brandt
Institute of Sports Science, University of the Bundeswehr Munich, 85579 Neubiberg, Germany
2 shared publications Andrea Schittenhelm
University of the Bundeswehr Munich, Germany, Institute of Sport Sciences, Germany
1 shared publication- Andreas Hirsch
Department of Chemistry and Pharmacy Chair of Organic Chemistry II Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Nikolaus‐Fiebiger‐Straße 10 91058 Erlangen Germany
1 shared publication - Bajramshahe Shkodra
Institute of Physics & Research Center SENS Faculty of Electric Power Systems and Information Technology University of the Bundeswehr Munich Neubiberg Germany
1 shared publication Eric Quarg
University of the Bundeswehr Munich, Germany, Institute of Sport Sciences, Germany
1 shared publication
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Small Science
- Vol. 6 (10) , e70405
Selective and Fast Cortisol Sensing in Human Saliva Using Graphene‐Based On‐Chip Field‐Effect Transistors
Monitoring of biomarkers in body fluids is highly sought after for medical diagnostics and tracking health conditions. Conventional analytical methods require centralized facilities and complex protocols, limiting applicability for real‐time or point‐of‐care use. In recent years, graphene‐based transducers have shown high potential for miniaturized biosensing, however they have so far been hardly tested in real‐case scenarios. In this work, electrolyte‐gated graphene field‐effect transistors (EG‐GFETs) are developed for the detection of the primary stress hormone cortisol in human saliva. The sensor consists of chemical vapor deposition (CVD)‐grown graphene functionalized with perylene bisimide (PBI) linkers for immobilizing anticortisol (17) Fab fragments. Cortisol is detected over a dynamic range from 100 fM to 1 μM, covering physiologically relevant concentration ranges. The measurements show high correlation with enzyme‐linked immunosorbent assay (ELISA) tests performed in parallel on the same samples. The immediate, label‐free sensing of biomarkers in human saliva represents a major advance in miniaturized biosensing and can potentially be extended to further analytes and integrated portable monitoring units.
- 27 September 2026
- Published by Wiley in Small Science
- Vol. 6 (10) , e70405
Open AccessSelective and Fast Cortisol Sensing in Human Saliva Using Graphene‐Based On‐Chip Field‐Effect Transistors
Monitoring of biomarkers in body fluids is highly sought after for medical diagnostics and tracking health conditions. Conventional analytical methods require centralized facilities and complex protocols, limiting applicability for real‐time or point‐of‐care use. In recent years, graphene‐based transducers have shown high potential for miniaturized biosensing, however they have so far been hardly tested in real‐case scenarios. In this work, electrolyte‐gated graphene field‐effect transistors (EG‐GFETs) are developed for the detection of the primary stress hormone cortisol in human saliva. The sensor consists of chemical vapor deposition (CVD)‐grown graphene functionalized with perylene bisimide (PBI) linkers for immobilizing anticortisol (17) Fab fragments. Cortisol is detected over a dynamic range from 100 fM to 1 μM, covering physiologically relevant concentration ranges. The measurements show high correlation with enzyme‐linked immunosorbent assay (ELISA) tests performed in parallel on the same samples. The immediate, label‐free sensing of biomarkers in human saliva represents a major advance in miniaturized biosensing and can potentially be extended to further analytes and integrated portable monitoring units.
- Open Access
- 13 September 2025
- Published by Elsevier in Neurobiology of Stress
- Vol. 39, 100760
Virtual stress testing: Analyzing endocrine, metabolic, cardiovascular, and psychological responses to the TSST-VR
- 13 September 2025
- Published by Elsevier in Neurobiology of Stress
- Vol. 39, 100760
Open AccessVirtual stress testing: Analyzing endocrine, metabolic, cardiovascular, and psychological responses to the TSST-VR
- Open Access
Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults
Continuous Glucose Monitoring (CGM) not only can be used for glycemic control in chronic diseases (e.g., diabetes), but is increasingly being utilized by individuals and athletes to monitor fluctuations in training and everyday life. However, it is not clear how accurately CGM reflects plasma glucose concentration in a healthy population in the absence of chronic diseases. In an oral glucose tolerance test (OGTT) with forty-four healthy male subjects (25.5 ± 4.5 years), the interstitial fluid glucose (ISFG) concentration obtained by a CGM sensor was compared against finger-prick capillary plasma glucose (CPG) concentration at fasting baseline (T0) and 30 (T30), 60 (T60), 90 (T90), and 120 (T120) min post OGTT to investigate differences in measurement accuracy. The overall mean absolute relative difference (MARD) was 12.9% (95%-CI: 11.8–14.0%). Approximately 100% of the ISFG values were within zones A and B in the Consensus Error Grid, indicating clinical accuracy. A paired t-test revealed statistically significant differences between CPG and ISFG at all time points (T0: 97.3 mg/dL vs. 89.7 mg/dL, T30: 159.9 mg/dL vs. 144.3 mg/dL, T60: 134.8 mg/dL vs. 126.2 mg/dL, T90: 113.7 mg/dL vs. 99.3 mg/dL, and T120: 91.8 mg/dL vs. 82.6 mg/dL; p < 0.001) with medium to large effect sizes (d = 0.57–1.02) and with ISFG systematically under-reporting the reference system CPG. CGM sensors provide a convenient and reliable method for monitoring blood glucose in the everyday lives of healthy adults. Nonetheless, their use in clinical settings wherein implications are drawn from CGM readings should be handled carefully.
Open AccessAnalytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults
Continuous Glucose Monitoring (CGM) not only can be used for glycemic control in chronic diseases (e.g., diabetes), but is increasingly being utilized by individuals and athletes to monitor fluctuations in training and everyday life. However, it is not clear how accurately CGM reflects plasma glucose concentration in a healthy population in the absence of chronic diseases. In an oral glucose tolerance test (OGTT) with forty-four healthy male subjects (25.5 ± 4.5 years), the interstitial fluid glucose (ISFG) concentration obtained by a CGM sensor was compared against finger-prick capillary plasma glucose (CPG) concentration at fasting baseline (T0) and 30 (T30), 60 (T60), 90 (T90), and 120 (T120) min post OGTT to investigate differences in measurement accuracy. The overall mean absolute relative difference (MARD) was 12.9% (95%-CI: 11.8–14.0%). Approximately 100% of the ISFG values were within zones A and B in the Consensus Error Grid, indicating clinical accuracy. A paired t-test revealed statistically significant differences between CPG and ISFG at all time points (T0: 97.3 mg/dL vs. 89.7 mg/dL, T30: 159.9 mg/dL vs. 144.3 mg/dL, T60: 134.8 mg/dL vs. 126.2 mg/dL, T90: 113.7 mg/dL vs. 99.3 mg/dL, and T120: 91.8 mg/dL vs. 82.6 mg/dL; p < 0.001) with medium to large effect sizes (d = 0.57–1.02) and with ISFG systematically under-reporting the reference system CPG. CGM sensors provide a convenient and reliable method for monitoring blood glucose in the everyday lives of healthy adults. Nonetheless, their use in clinical settings wherein implications are drawn from CGM readings should be handled carefully.